Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T A Ban

Showing results (81-90 of 257) with videos related to

Pageof 26
Sort By:
Current Therapeutic Research, Clinical and Experimental|April 1, 1972
The place of doxepin among the anxiolytic-sedative drugsC Sterlin, T A Ban, L Jarrold
Current Therapeutic Research, Clinical and Experimental|October 1, 1973
Trazodone in the treatment of affective disordersM Amin, T A Ban, A Klingner
Comprehensive Psychiatry|November 1, 1982
Neurotoxicity with combined administration of lithium and a neurolepticR Prakash, S Kelwala, T A Ban
Comprehensive Psychiatry|May 1, 1982
Neurotoxicity in patients with schizophrenia during lithium therapyR Prakash, S Kelwala, T A Ban
Canadian Psychiatric Association Journal|April 1, 1973
Comparing facilities in a psychiatric unit of a general hospital and an admission unit of a psychiatric hospitalT A Ban, A Klingner, H Warnes
Current Therapeutic Research, Clinical and Experimental|April 1, 1972
The place of thiothixene among the thioxanthenesC Sterlin, T A Ban, L Jarrold
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|October 1, 1984
The psychopharmacological treatment of depression in the medically ill patientT A Ban, W Guy, W H Wilson
Neuropsychobiology|January 1, 1983
Organizing and conducting clinical trialsT A Ban, W Guy, W H Wilson
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1985
An international survey of tardive dyskinesiaW Guy, T A Ban, W H Wilson
Psychopharmacology Communications|January 1, 1975
Ascorbic acid levels in chronic psychotic patientsP Clement, T A Ban, H E Lehmann
Pageof 26

Showing results (81-90 of 257) with videos related to

Sort By:
Pageof 26
Current Therapeutic Research, Clinical and Experimental|April 1, 1972
The place of doxepin among the anxiolytic-sedative drugsC Sterlin, T A Ban, L Jarrold
Current Therapeutic Research, Clinical and Experimental|October 1, 1973
Trazodone in the treatment of affective disordersM Amin, T A Ban, A Klingner
Comprehensive Psychiatry|November 1, 1982
Neurotoxicity with combined administration of lithium and a neurolepticR Prakash, S Kelwala, T A Ban
Comprehensive Psychiatry|May 1, 1982
Neurotoxicity in patients with schizophrenia during lithium therapyR Prakash, S Kelwala, T A Ban
Canadian Psychiatric Association Journal|April 1, 1973
Comparing facilities in a psychiatric unit of a general hospital and an admission unit of a psychiatric hospitalT A Ban, A Klingner, H Warnes
Current Therapeutic Research, Clinical and Experimental|April 1, 1972
The place of thiothixene among the thioxanthenesC Sterlin, T A Ban, L Jarrold
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|October 1, 1984
The psychopharmacological treatment of depression in the medically ill patientT A Ban, W Guy, W H Wilson
Neuropsychobiology|January 1, 1983
Organizing and conducting clinical trialsT A Ban, W Guy, W H Wilson
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1985
An international survey of tardive dyskinesiaW Guy, T A Ban, W H Wilson
Psychopharmacology Communications|January 1, 1975
Ascorbic acid levels in chronic psychotic patientsP Clement, T A Ban, H E Lehmann
Pageof 26